454 Shares in McKesson Co. (NYSE:MCK) Acquired by Wayfinding Financial LLC

Wayfinding Financial LLC acquired a new stake in McKesson Co. (NYSE:MCK - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 454 shares of the company's stock, valued at approximately $259,000.

Other hedge funds have also made changes to their positions in the company. Synergy Asset Management LLC acquired a new position in shares of McKesson during the fourth quarter worth about $32,000. Crews Bank & Trust purchased a new position in shares of McKesson during the 4th quarter worth approximately $33,000. Atala Financial Inc acquired a new stake in shares of McKesson in the 4th quarter valued at approximately $34,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of McKesson in the third quarter valued at approximately $31,000. Finally, Creative Capital Management Investments LLC acquired a new position in McKesson during the fourth quarter worth $44,000. Institutional investors and hedge funds own 85.07% of the company's stock.

McKesson Stock Performance

Shares of MCK stock traded up $1.85 during trading hours on Tuesday, reaching $662.71. The company had a trading volume of 710,699 shares, compared to its average volume of 802,124. The stock's fifty day simple moving average is $619.05 and its 200 day simple moving average is $576.50. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $670.79. The company has a market capitalization of $83.05 billion, a P/E ratio of 30.34, a price-to-earnings-growth ratio of 1.29 and a beta of 0.52.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. As a group, equities analysts expect that McKesson Co. will post 32.77 earnings per share for the current year.

Remove Ads

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 3rd will be issued a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a yield of 0.43%. The ex-dividend date is Monday, March 3rd. McKesson's dividend payout ratio is currently 13.00%.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Leann B. Smith sold 188 shares of the firm's stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total transaction of $114,602.92. Following the completion of the transaction, the executive vice president now directly owns 1,051 shares of the company's stock, valued at $640,679.09. This trade represents a 15.17 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Brian S. Tyler sold 8,961 shares of the company's stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the completion of the sale, the chief executive officer now owns 60,664 shares in the company, valued at approximately $36,276,465.36. This trade represents a 12.87 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 18,689 shares of company stock worth $11,187,351 in the last 90 days. 0.11% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have commented on MCK. Citigroup decreased their target price on shares of McKesson from $713.00 to $677.00 and set a "buy" rating on the stock in a research report on Friday, January 10th. Evercore ISI upped their target price on shares of McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a research report on Thursday, February 6th. StockNews.com cut McKesson from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th. Bank of America reduced their price objective on McKesson from $680.00 to $650.00 and set a "buy" rating for the company in a report on Monday, January 6th. Finally, Morgan Stanley boosted their target price on McKesson from $612.00 to $642.00 and gave the stock an "overweight" rating in a research report on Tuesday, December 17th. Two analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $649.36.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.